Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Tolerability and Preferences of Per Oral or Subcutaneous Methotrexate in Patients with Early Rheumatoid Arthritis - a Randomised Register Based Multicentre Study

NCT05353829 is registered in ClinicalTrials.gov with Region Västerbotten as lead sponsor.

NCT NCT05353829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05353829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Tolerability and Preferences of Per Oral or Subcutaneous Methotrexate in Patients with Early Rheumatoid Arthritis - a Randomised Register Based Multicentre Study
Lead sponsor
Region Västerbotten
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 28, 2022
Completion date
December 31, 2026
Enrollment
212 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis